Acute childhood leukemia and Occlusion - renal artery

Summary:

Occlusion - renal artery is found among people with Acute childhood leukemia, especially for people who are female, 60+ old.

The study analyzes which people have Occlusion - renal artery with Acute childhood leukemia. It is created by eHealthMe based on reports of 7 people who have Acute childhood leukemia from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Feb, 07, 2023

7 people who have Acute Childhood Leukemia and Occlusion - Renal Artery are studied.


What is Acute childhood leukemia?

Acute childhood leukemia (acute childhood blood cancer) is found to be associated with 990 drugs and 776 conditions by eHealthMe.

What is Occlusion - renal artery?

Occlusion - renal artery (a blockage of the major arteries that supply blood to the kidneys) is found to be associated with 1,225 drugs and 705 conditions by eHealthMe.

Number of Occlusion - renal artery in Acute childhood leukemia reports submitted per year:

Would you have Occlusion - renal artery when you have Acute childhood leukemia?

Gender of people who have Acute Childhood Leukemia and experienced Occlusion - Renal Artery *:

  • female: 60 %
  • male: 40 %

Age of people who have Acute Childhood Leukemia and experienced Occlusion - Renal Artery *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 50 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 50 %

Common co-existing conditions for these people *:

  1. Pain: 2 people, 28.57%

Common drugs taken by these people *:

  1. Iclusig: 5 people, 71.43%
  2. Versed: 2 people, 28.57%
  3. Oxycontin: 2 people, 28.57%
  4. Heparin: 2 people, 28.57%
  5. Dasatinib: 2 people, 28.57%

Common symptoms for these people *:

  1. Mesenteric Artery Stenosis (narrowing of the arteries supplying blood to the intestines): 4 people, 57.14%
  2. Peripheral Arterial Occlusive Disease (reproducible ischemic muscle pain): 3 people, 42.86%
  3. Neuropathy Peripheral (surface nerve damage): 3 people, 42.86%
  4. Mobility Decreased (ability to move is reduced): 3 people, 42.86%
  5. Ventricular Hypokinesia (muscle of one's heart does not contract as much as most peoples' hearts do): 2 people, 28.57%
  6. Gangrene (body tissue dies): 2 people, 28.57%
  7. Cardiac Failure Acute: 2 people, 28.57%
  8. Coronary Artery Stenosis (narrowing of coronary artery): 2 people, 28.57%
  9. Dyspnea Exertional: 2 people, 28.57%
  10. Hyperglycemia (high blood sugar): 2 people, 28.57%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Occlusion - renal artery?

Check whether Occlusion - renal artery is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Treatments, associated drugs and conditions:

COVID vaccines that are related to Occlusion - renal artery:

Common drugs associated with Occlusion - renal artery:

All the drugs that are associated with Occlusion - renal artery:

Common conditions associated with Occlusion - renal artery:

All the conditions that are associated with Occlusion - renal artery:

How the study uses the data?

The study is based on Occlusion - renal artery and Acute childhood leukemia, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: